![Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/1/35/F1.large.jpg)
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology
![Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-020-03941-8/MediaObjects/12891_2020_3941_Fig2_HTML.png)
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study | BMC Musculoskeletal Disorders | Full Text
![Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open](https://rmdopen.bmj.com/content/rmdopen/8/1/e001955/F3.large.jpg)
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation | RMD Open
![PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study](https://www.researchgate.net/publication/349041855/figure/fig1/AS:987856487075841@1612534748997/Flow-chart-of-patient-selection-BASDAI-Bath-Ankylosing-Spondylitis-Disease-Activity_Q320.jpg)
PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study
![PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study PDF) Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study](https://i1.rgstatic.net/publication/349041855_Low_BASDAI_score_alone_is_not_a_good_predictor_of_anti-tumor_necrosis_factor_treatment_efficacy_in_ankylosing_spondylitis_a_retrospective_cohort_study/links/601d53db299bf1cc26a6b2d8/largepreview.png)